Compound ID | 301
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Demonstrates high stability against DHP-1. Lenapenem performed better against MRSA than imipenem |
Description: | Izumi K, Mikamo H, Kawazoe K, et al. In vitro and in vivoantibacterial activities of BO-2727 in the fields of obstetrics and Gynecology. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 137. |
Institute where first reported: | Banyu; Merck and Co. |
Year first mentioned: | 1990 |
Highest developmental phase: | Phase 2 |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/216262 |
Guide to Pharmacology: | lenapenem |
Citations: |
|